Endovascular Therapy for Chronic Mesenteric Ischemia

Area of Science:

• Vascular Surgery
• Gastroenterology
• Interventional Radiology

Background:

• Chronic mesenteric ischemia (CMI) stems from atherosclerosis in mesenteric blood vessels, affecting women more than men.
• Risk factors include smoking, hypertension, dyslipidemia, and older age, leading to postprandial pain and weight loss.
• Untreated CMI can result in severe malnutrition, with limited evidence for medical therapies in preventing disease progression.

Purpose of the Study:

• To review the current understanding of chronic mesenteric ischemia (CMI).
• To discuss the limitations of medical management for CMI.
• To highlight the shift towards endovascular revascularization as a primary treatment.

Main Methods:

• Review of existing literature and consensus guidelines on CMI.
• Analysis of risk factors, clinical presentation, and outcomes.
• Comparison of surgical versus endovascular revascularization approaches.

Main Results:

• Atherosclerotic disease is the primary cause of CMI, with specific risk factors identified.
• Clinical symptoms include postprandial abdominal pain and significant weight loss.
• Endovascular techniques have emerged as a preferred first-line treatment over traditional surgical bypass due to reduced perioperative risks.

Conclusions:

• CMI requires effective management strategies due to potential malnutrition.
• Medical therapy lacks proven efficacy in halting mesenteric atherosclerosis progression.
• Endovascular therapy offers a safer and effective alternative for revascularization in CMI patients.